EHMT2 and gastric cancer: The knockdown of either STAT3 or G9a, or treatment with a G9a inhibitor, BIX-01294, yielded similar outcomes as SH003 treatment, suggesting that the STAT3-G9a complex enables GC cells to evade autophagy.